PVLA · Insider trading · 13F holders · Congress trades
Palvella Therapeutics, Inc. (PVLA)
Who is buying and selling PVLA: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 19
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $9.6M
- Congress trades, 12 months
- 0
PVLA at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 3 PVLA insiders filed 6 sales worth $9.6M on SEC Form 4, and no open-market purchases; 5 of the sales were pre-planned under Rule 10b5-1.
- 19 13F filers hold PVLA among their 50 largest positions, worth $868.6M combined. The biggest bets by portfolio weight are Clio Asset Management LLC (10.0%), First Light Asset Management, LLC (7.2%) and NEXTBio Capital Management LP (6.3%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in PVLA.
- PVLA last closed at $151.58 on Oct 29, 2026.
PVLA insider trading
Between Aug 1, 2026 and Oct 29, 2026, 3 PVLA insiders filed 6 sales worth $9.6M on SEC Form 4, and no open-market purchases; 5 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Goin Kathleen | Chief Operating Officer | Sale10b5-1 | 4,313 | $124.58 | $537K | SEC |
| Oct 14, 2026 | Jenkins George M | Director | Sale10b5-1 | 27,500 | $130.16 | $3.6M | SEC |
| Sep 18, 2026 | Goin Kathleen | Chief Operating Officer | Sale10b5-1 | 4,302 | $152.24 | $655K | SEC |
| Sep 15, 2026 | Jenkins George M | Director | Sale10b5-1 | 27,500 | $151.53 | $4.2M | SEC |
| Sep 4, 2026 | Kiritsy Christopher P | Director | Sale | 313 | $157.00 | $49K | SEC |
| Aug 20, 2026 | Goin Kathleen | Chief Operating Officer | Sale10b5-1 | 4,302 | $152.21 | $655K | SEC |
Who owns PVLA? Hedge funds and superinvestors
19 13F filers hold PVLA among their 50 largest positions, worth $868.6M combined. The biggest bets by portfolio weight are Clio Asset Management LLC (10.0%), First Light Asset Management, LLC (7.2%) and NEXTBio Capital Management LP (6.3%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Montanova Capital, LLCHedge fund | 3.6% | $173.5M | 1,135,406 | -1.6% shares | Q2 2026 |
| Frazier Life Sciences Management, L.P.Hedge fund | 2.9% | $134.8M | 882,400 | +0.0% shares | Q2 2026 |
| First Light Asset Management, LLCHedge fund | 7.2% | $118.0M | 771,901 | -21.3% shares | Q2 2026 |
| Bvf Inc/ilInvestment manager | 2.6% | $102.8M | 672,789 | -30.0% shares | Q2 2026 |
| Frontier Capital Management Co LLCInstitutional asset manager | 0.7% | $73.2M | 478,833 | — | Q2 2026 |
| Orbimed Advisors LLCHedge fund | 0.8% | $44.7M | 292,360 | — | Q2 2026 |
| Siren, L.L.C.Investment manager | 0.8% | $39.3M | 257,485 | +0.0% shares | Q2 2026 |
| Emerald Advisers, LLCInstitutional asset manager | 0.8% | $35.1M | 229,486 | — | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 1.9% | $31.2M | 204,027 | -1.2% shares | Q2 2026 |
| First Turn Management, LLCInstitutional asset manager | 2.6% | $23.9M | 156,450 | +5.6% shares | Q2 2026 |
| Bellevue Group AGInvestment manager | 0.5% | $23.7M | 155,000 | — | Q2 2026 |
| NEXTBio Capital Management LPHedge fund | 6.3% | $13.7M | 89,909 | +8.7% shares | Q2 2026 |
| Clio Asset Management LLCWealth manager | 10.0% | $11.9M | 86,012 | -0.4% shares | Q3 2026 |
| Avidity Partners Management LPHedge fund | 1.7% | $10.7M | 70,000 | +0.0% shares | Q2 2026 |
| AWM Investment Company, Inc.Hedge fund | 0.9% | $10.6M | 69,416 | +0.0% shares | Q2 2026 |
| Lisanti Capital Growth, LLCInstitutional asset manager | 1.4% | $6.6M | 42,975 | +3.7% shares | Q2 2026 |
| Apis Capital Advisors, LLCHedge fund | 0.6% | $6.0M | 39,000 | -56.2% shares | Q2 2026 |
| Blue Owl Capital Holdings LPHedge fund | 0.8% | $5.5M | 36,259 | +16.0% shares | Q2 2026 |
| Act Capital Management, LLCHedge fund | 2.2% | $3.4M | 22,500 | — | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 18). Screen PVLA in the grand portfolio →
PVLA stock trades by members of Congress
No member of Congress has disclosed a trade in PVLA.
PVLA questions and answers
Are insiders buying PVLA stock?
Between Aug 1, 2026 and Oct 29, 2026, 3 PVLA insiders filed 6 sales worth $9.6M on SEC Form 4, and no open-market purchases; 5 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own PVLA?
19 13F filers hold PVLA among their 50 largest positions, worth $868.6M combined. The biggest bets by portfolio weight are Clio Asset Management LLC (10.0%), First Light Asset Management, LLC (7.2%) and NEXTBio Capital Management LP (6.3%). In their latest 13Fs, 0 managers opened a new position and 3 added to one.
Has Congress traded PVLA?
No member of Congress has disclosed a trade in PVLA.
Who is the largest holder of PVLA?
Among 13F filers, Montanova Capital, LLC reports the largest PVLA position, $173.5M (1,135,406 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Clio Asset Management LLC's: 10.0% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.